Medical stocks are stocks of the companies involved in medical technology. Such companies manufacture medical devices and perform extensive research and development in the field of medicine. Medical technology companies also include medical systems companies, medical aesthetics companies, medical equipment companies, medical labs, and drug makers.
The performance of medical stocks is measured in terms of Composite Ratings, and most of them have very high composite ratings of around 95. It implies that in the most recent times, medical stocks have outperformed 95% of all other stocks. With the ever booming increase in science and technology, Medical stocks have had a good run in 2019 and have generated high returns.
Ticker | Company Name | Last Price | 1-Year Return | Market Cap |
|---|---|---|---|---|
| ABT | Abbott Laboratories | $128.51 | 20.76% | 227.8B |
| MDT | Medtronic plc | $122.38 | 19.29% | 164.7B |
| SYK | Stryker Corporation | $269.32 | 31.41% | 101.6B |
| BSX | Boston Scientific Corporation | $43.61 | 28.00% | 62.1B |
| EW | Edwards Lifesciences Corporation | $113.82 | 55.36% | 70.9B |
| ZBH | Zimmer Biomet Holdings, Inc. | $146.65 | 9.96% | 30.6B |
| ALGN | Align Technology, Inc. | $624.98 | 42.20% | 49.4B |
| SNN | Smith & Nephew plc | $35.69 | 0.11% | 11.3B |
| ABMD | Abiomed, Inc. | $336.80 | 19.01% | 15.3B |
| NVCR | NovoCure Limited | $102.31 | -11.34% | 10.6B |
| GMED | Globus Medical, Inc. | $77.61 | 56.41% | 7.8B |
| NUVA | NuVasive, Inc. | $53.31 | 11.74% | 2.8B |
| LIVN | LivaNova PLC | $78.24 | 57.01% | 4.2B |
| SDC | SmileDirectClub, Inc. | $5.23 | -44.48% | 2.0B |
| NVRO | Nevro Corp. | $116.73 | -21.37% | 4.1B |
| CNMD | CONMED Corporation | $144.90 | 82.42% | 4.2B |
| ITGR | Integer Holdings Corporation | $94.39 | 54.89% | 3.1B |
| PBH | Prestige Consumer Healthcare Inc. | $59.25 | 81.25% | 3.0B |
| BDX | Becton, Dickinson and Company | $244.55 | 3.67% | 70.2B |
| ISRG | Intuitive Surgical, Inc. | $353.84 | 54.33% | 126.3B |
| ILMN | Illumina, Inc. | $417.80 | 34.91% | 61.2B |
| BAX | Baxter International Inc. | $82.71 | 5.83% | 41.3B |
| ALC | Alcon, Inc. | $82.79 | 41.69% | 37.8B |
| RMD | ResMed Inc. | $274.34 | 51.85% | 39.9B |
| MTD | Mettler-Toledo International Inc. | $1,483.49 | 46.99% | 34.3B |
| TFX | Teleflex Incorporated | $356.78 | 6.49% | 16.7B |
| COO | The Cooper Companies, Inc. | $417.46 | 25.15% | 20.6B |
| WAT | Waters Corporation | $364.36 | 62.10% | 22.3B |
| HOLX | Hologic, Inc. | $72.46 | 3.97% | 18.4B |
| XRAY | DENTSPLY SIRONA Inc. | $57.64 | 28.55% | 12.6B |
| STE | STERIS plc | $234.14 | 31.08% | 23.4B |
| VAR | Varian Medical Systems, Inc. | $0.20 | 42.86% | 2.5M |
| WST | West Pharmaceutical Services, Inc. | $420.90 | 50.19% | 31.1B |
| PODD | Insulet Corporation | $303.33 | 32.80% | 20.9B |
| MASI | Masimo Corporation | $289.60 | 23.97% | 15.9B |
| HRC | Hill-Rom Holdings, Inc. | $155.00 | 69.84% | 10.2B |
| HAE | Haemonetics Corporation | $68.63 | -33.66% | 3.5B |
| PEN | Penumbra, Inc. | $277.23 | 19.13% | 10.1B |
| TMO | Thermo Fisher Scientific Inc. | $620.74 | 30.21% | 244.4B |
| IQV | IQVIA Holdings Inc. | $256.08 | 64.46% | 49.1B |
| A | Agilent Technologies, Inc. | $156.90 | 54.34% | 47.5B |
| DXCM | DexCom, Inc. | $558.74 | 60.04% | 54.1B |
| LH | Laboratory Corporation of America Holdings | $284.97 | 39.69% | 27.5B |
| DGX | Quest Diagnostics Incorporated | $146.09 | 16.90% | 17.8B |
| BIO | Bio-Rad Laboratories, Inc. | $774.25 | 38.39% | 22.8B |
| EXAS | Exact Sciences Corporation | $96.80 | -24.09% | 16.6B |
| PKI | PerkinElmer, Inc. | $176.00 | 41.48% | 19.7B |
| ICLR | ICON Public Limited Company | $282.67 | 54.90% | 22.5B |
| BRKR | Bruker Corporation | $79.21 | 92.07% | 12.0B |
| GH | Guardant Health, Inc. | $116.00 | 4.98% | 11.8B |
| CRL | Charles River Laboratories International, Inc. | $437.06 | 96.87% | 22.0B |
| PRAH | PRA Health Sciences, Inc. | #N/A | #N/A | #N/A |
| SYNH | Syneos Health, Inc. | $89.01 | 66.78% | 9.2B |
| NTRA | Natera, Inc. | $117.91 | 76.88% | 11.1B |
| MEDP | Medpace Holdings, Inc. | $214.44 | 91.41% | 7.7B |
| NEO | NeoGenomics, Inc. | $45.70 | 14.68% | 5.6B |
| JNJ | Johnson & Johnson | $164.71 | 19.04% | 433.6B |
| NVS | Novartis AG | $83.66 | 6.76% | 206.0B |
| MRK | Merck & Co., Inc. | $85.49 | 17.69% | 216.4B |
| PFE | Pfizer Inc. | $43.34 | 29.06% | 243.0B |
| AMGN | Amgen Inc. | $208.39 | -3.69% | 118.3B |
| ABBV | AbbVie Inc. | $109.20 | 35.67% | 193.0B |
| AZN | AstraZeneca PLC | $62.49 | 22.58% | 192.7B |
| SNY | Sanofi | $50.35 | 9.12% | 126.6B |
| GSK | GlaxoSmithKline plc | $41.92 | 23.48% | 103.6B |
| LLY | Eli Lilly and Company | $253.50 | 93.05% | 242.5B |
| BMY | Bristol-Myers Squibb Company | $57.25 | -0.88% | 127.2B |
| GILD | Gilead Sciences, Inc. | $67.37 | 14.73% | 84.5B |
| BIIB | Biogen Inc. | $263.72 | 7.97% | 38.7B |
| GRFS | Grifols, S.A. | $13.36 | -22.91% | 13.5B |
| GWPH | GW Pharmaceuticals plc | #N/A | #N/A | #N/A |
| HCM | Hutchison China MediTech Limited | $30.09 | 1.59% | 3.8B |
| HRTX | Heron Therapeutics, Inc. | $11.01 | -27.71% | 1.1B |
| TEVA | Teva Pharmaceutical Industries Limited | $8.72 | -0.46% | 10.0B |
| RDY | Dr. Reddy's Laboratories Limited | $61.06 | -5.90% | 10.2B |
| CGC | Canopy Growth Corporation | $13.11 | -28.52% | 6.3B |
| ACB | Aurora Cannabis Inc. | $7.00 | 82.77% | 1.7B |
| TARO | Taro Pharmaceutical Industries Ltd. | $60.80 | 5.23% | 2.3B |
| TLRY | Tilray, Inc. | $10.54 | 86.55% | 4.9B |
| APHA | Aphria Inc. | #N/A | #N/A | #N/A |
| TAK | Takeda Pharmaceutical Company Limited | $14.21 | -11.74% | 45.4B |
| AGN | Allergan plc | $0.08 | -70.37% | 11.7M |
| ZTS | Zoetis Inc. | $212.64 | 34.00% | 100.8B |
| ELAN | Elanco Animal Health Incorporated | $32.59 | 5.91% | 15.4B |
| MYL | Mylan N.V. | $0.70 | -5.41% | 133.1M |
| CTLT | Catalent, Inc. | $135.10 | 51.92% | 23.1B |
| HZNP | Horizon Therapeutics Public Limited Company | $116.32 | 50.56% | 26.3B |
| TCDA | Tricida, Inc. | $4.51 | -45.47% | 227.4M |
| PCRX | Pacira BioSciences, Inc. | $51.41 | -1.27% | 2.3B |
| IRWD | Ironwood Pharmaceuticals, Inc. | $12.65 | 33.16% | 2.1B |
| SUPN | Supernus Pharmaceuticals, Inc. | $29.67 | 67.63% | 1.6B |
Factors to Consider Before Investing in Medical Stocks
Medical stocks follow a high-risk high-reward profile. The success or failure of medical technology companies largely rely on the acceptance or non-acceptance of innovative products, and the results of new research and development.
However, medical stocks are still less volatile and risky than biotechnology and pharmaceutical stocks as political and regulatory concerns do not plague them.
Before investing in medical stocks, investors must consider the composite ratings of the stocks. Additionally, investors must consider the fundamentals of the companies, including revenues, earnings growth, P/E ratios, and dividend yield.
Which Medical Stocks Should I Buy?
Several medical stocks trade on the stock exchanges. Among them, we have shortlisted the best medical stocks for your reference. Investors should apply extensive research, analysis, and due diligence before picking suitable stocks for them.
Investors must note that medical stocks are more suitable for long-term capital gains rather than short-term dividend income. Therefore, the dividend yield should not be the deciding factor. Instead, investors must look for the overall strength of the companies’ fundamentals, innovation, the efficiency of the research & development teams, and market capitalization of companies before investing in medical stocks.
